Bioventus Inc.
BVS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001665988
No open-market purchases or sales by Bioventus Inc. insiders were filed in the last 90 days; 156 institutions reported holding it in 13F filings for Q2 2026, worth $509.4M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Bioventus Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- +7 vs. Q4 2021
- Shares held
- 31.7M
- +531.4K (+1.7%) vs. Q4 2021
- Total value
- $447.0M
- −$4.63M (−1.0%) vs. Q4 2021
- New holders
- 22
- 32 more added
- Sold out
- 15
- 41 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 156 | $509.4M |
| Q1 2026 | 157 | $466.4M |
| Q4 2025 | 148 | $373.3M |
| Q3 2025 | 135 | $328.9M |
| Q2 2025 | 134 | $320.3M |
| Q1 2025 | 144 | $427.0M |
| Q4 2024 | 151 | $477.8M |
| Q3 2024 | 138 | $537.1M |
| Q2 2024 | 103 | $222.2M |
| Q1 2024 | 84 | $178.0M |
| Q4 2023 | 80 | $175.4M |
| Q3 2023 | 67 | $108.9M |
| Q2 2023 | 66 | $92.6M |
| Q1 2023 | 71 | $33.4M |
| Q4 2022 | 85 | $81.9M |
| Q3 2022 | 94 | $245.9M |
| Q2 2022 | 98 | $232.0M |
| Q1 2022 | 105 | $447.0M |
| Q4 2021 | 98 | $451.6M |
| Q3 2021 | 69 | $351.8M |
| Q2 2021 | 53 | $364.5M |
| Q1 2021 | 45 | $334.2M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Bioventus Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SV Health Investors, LLC | 1,488,596 | $21.0M | 25.35% | −92,435−5.8% | Reduced |
| BlackRock Inc. | 1,783,087 | $25.1M | 0.00% | −31,945−1.8% | Reduced |
| Royce & Associates LP | 1,943,183 | $27.4M | 0.23% | +154,978+8.7% | Added |
| Juniper Investment Company, LLC | 2,761,657 | $38.9M | 24.42% | +13,450+0.5% | Added |
| Essex Woodlands Management, Inc. | 12,096,702 | $170.6M | 41.24% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −428,397−100.0% | Sold out |
| Acuitas Investments, LLC | 0 | $0 | 0.00% | −114,100−100.0% | Sold out |
| Meros Investment Management, LP | 0 | $0 | 0.00% | −114,100−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −52,004−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −23,293−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −17,900−100.0% | Sold out |
| MML Investors Services, LLC | 0 | $0 | 0.00% | −15,610−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −13,621−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −13,271−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −12,355−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −7,400−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −715−100.0% | Sold out |
| Fieldpoint Private Securities, LLC | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| Delos Wealth Advisors, LLC | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −21−100.0% | Sold out |